地夫立群
|
|
- CAS号:
- 239101-33-8
- 英文名:
- Deferitrin
- 英文别名:
- CS-911;AC1OCFQP;GT 56-252;Deferitrin;UNII-T69Y9LDN44;(S)-4'-(HO)-DADFT;Deferitrin (USAN/INN); NSC 405020Deferitrin;Deferitrin (GT-56-252);4,5-Dihydro-2-(2,4-dihydroxyphenyl)-4-methylthiazol-4-(S)-carboxylic acid
- 中文名:
- 地夫立群
- 中文别名:
- 地夫立群
- CBNumber:
- CB11856036
- 分子式:
- C11H11NO4S
- 分子量:
- 253.27
- MOL File:
- 239101-33-8.mol
|
|
|
地夫立群化学性质
-
熔点:
-
281-283℃ (decomposition)
-
|
-
储存条件:
-
-20°C
-
|
-
溶解度:
-
DMF: 10 mg/mL,DMSO: 12 mg/mL,Ethanol: Slightly soluble,PBS (pH 7.2): 0.2 mg/mL
-
|
-
形态:
-
A solid
-
|
地夫立群性质、用途与生产工艺
Deferitrin (GT-56-252) 是一种去铁硫素 (DFT) 类似物,是一种具有口服活性的三叉戟铁螯合剂。Deferitrin 用于输血引起的慢性铁超负荷。Deferitrin 有用于严重的 β 地中海贫血的潜力。
The iron-clearing efficiency (ICE) of Deferitrin (GT-56-252) in a non-iron-overloaded rodent model after oral (po) administration at 300 µmol/kg is shown to be 1.1%.
地夫立群
上下游产品信息
上游原料
下游产品
239101-33-8, 地夫立群 相关搜索:
- 地夫立群
- 239101-33-8
- Inhibitor,chelator,orally,overload,iron,beta-thalassemia,desferrithiocin,chronic,inhibit,therapy,Deferitrin,trident,transfusional
- 4-Thiazolecarboxylic acid, 2-(2,4-dihydroxyphenyl)-4,5-dihydro-4-methyl-, (4S)-
- (2Z,4S)-2-(2-hydroxy-4-oxocyclohexa-2,5-dien-1-ylidene)-4-methyl-1,3-thiazolidine-4-carboxylic acid
- UNII-T69Y9LDN44
- DEFERITRIN; 239101-33-8; AC1OCFQP; DEFERITRIN (USAN/INN); UNII-T69Y9LDN44; (S)-4'-(HO)-DADFT; GT-56252; GT 56-252
- Deferitrin (USAN/INN)
- AC1OCFQP
- NSC 405020Deferitrin
- (S)-4'-(HO)-DADFT
- CS-911
- GT 56-252
- 4,5-Dihydro-2-(2,4-dihydroxyphenyl)-4-methylthiazol-4-(S)-carboxylic acid
- Deferitrin (GT-56-252)
- Deferitrin